Singapore markets close in 1 hour 52 minutes

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
6.03+0.18 (+3.08%)
At close: 03:59PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
20,184
17,203
9,679
859.781
2,942
Selling general and administrative
9,465
5,808
8,887
1,270
3,015
Total operating expenses
30,228
23,204
18,678
2,246
6,159
Operating income or loss
-30,228
-23,204
-18,678
-2,246
-6,159
Interest expense
1,905
1,588
1,297
1,882
1,464
Total other income/expenses net
-2,884
305.753
-3,461
116.761
369.698
Income before tax
-34,104
-23,917
-23,370
-4,011
-7,241
Income from continuing operations
-34,104
-23,917
-23,370
-4,011
-7,241
Net income
-33,354
-23,259
-22,990
-3,997
-7,176
Net income available to common shareholders
-33,354
-23,259
-22,990
-3,997
-7,176
Basic EPS
-1.26
-1.24
-1.88
-0.31
-0.56
Diluted EPS
-1.26
-1.24
-1.88
-0.31
-0.56
Basic average shares
21,671
19,285
12,406
12,865
12,865
Diluted average shares
21,671
19,285
12,406
12,865
12,865